Delusions

Also known as: Delusion / Delusional thinking / Delusion NOS / Delusions (finding) / Delusional symptoms

Drug	Drug Name	Drug Description
DB05316	Pimavanserin	A second generation atypical antipsychotic used for the treatment of hallucinations and delusions caused by Parkinson's Disease.

Drug	Drug Name	Target	Type
DB05316	Pimavanserin	5-hydroxytryptamine receptor 2A	target
DB05316	Pimavanserin	5-hydroxytryptamine receptor 2C	target
DB05316	Pimavanserin	Sigma non-opioid intracellular receptor 1	target
DB05316	Pimavanserin	Cytochrome P450 3A4	enzyme
DB05316	Pimavanserin	Cytochrome P450 3A5	enzyme
DB05316	Pimavanserin	Cytochrome P450 2J2	enzyme
DB05316	Pimavanserin	Cytochrome P450 2D6	enzyme

Drug	Drug Name	Phase	Status	Count